SPH Notice – FMR LLC

100080615/3821102.1
1
Disclosure of beginning to have substantial holding
Section 276, Financial Markets Conduct Act 2013
Note: This form must be completed in accordance with the instructions at the end of the
form.
To New Zealand Stock Exchange
and
To Ryman Healthcare Ltd.
Date this disclosure made:11 May 2018
Date on which substantial holding began:10 May 2018
Substantial product holder(s) giving disclosure
Full name(s): FMR LLC and the entities listed in Annexure A (“FMR”)
Summary of substantial holding
Class of quoted voting products: Ordinary Shares
Summary for FMR
For this disclosure,—
(a) total number held in class: 25,464,919
(b) total in class: 500,000,000
(c) total percentage held in class: 5.09%
Details of relevant interests
Details for Refer to Annexure A
Nature of relevant interest(s): investment discretion and/or voting power
For that relevant interest,—
(a) number held in class: Refer to Annexure A
(b) percentage held in class: Refer to Annexure A
(c) current registered holder(s): Refer to Annexure A
(d) registered holder(s) once transfers are registered: N/A
For a derivative relevant interest, also—
(a) type of derivative: N/A
(b) details of derivative: N/A

100080615/3821102.1
2
(c) parties to the derivative: N/A
(d) if the substantial product holder is not a party to the derivative, the nature of the
relevant interest in the derivative: N/A
Details of transactions and events giving rise to substantial holding
Details of the transactions or other events requiring disclosure:
Date of
Acquisition
Holder of Relevant
Interest
Consideration
Class and Number of
Securities
NZD Common stock
10-Jan-18 FMR 11.17 8,922
19-Jan-18 FMR 10.40 5,845
02-Feb-18 FMR 10.91 12,339
08-Feb-18 FMR 10.81 46,653
08-Feb-18 FMR 10.81 47,507
14-Feb-18 FMR 10.51 21,357
21-Feb-18 FMR 10.59 379
21-Feb-18 FMR 10.59 19,488
27-Feb-18 FMR 10.57 12,838
28-Feb-18 FMR 10.67 28,204
12-Mar-18 FMR 10.61 30,442
15-Mar-18 FMR 10.59 408
15-Mar-18 FMR 10.59 83
19-Mar-18 FMR 10.71 12,703
20-Mar-18 FMR 10.85 9,283
21-Mar-18 FMR 11.10 4,001
21-Mar-18 FMR 11.10 15,350
28-Mar-18 FMR 10.48 6,696
29-Mar-18 FMR 10.59 8,093
29-Mar-18 FMR 10.59 168
03-Apr-18 FMR 10.50 13,090
04-Apr-18 FMR 10.60 4,056
16-Apr-18 FMR 10.68 20,033
16-Apr-18 FMR 10.68 9,763
17-Apr-18 FMR 10.65 183
17-Apr-18 FMR 10.65 9,311
17-Apr-18 FMR 10.65 294
26-Apr-18 FMR 10.41 200
30-Apr-18 FMR 10.60 13,282
30-Apr-18 FMR 10.60 6,605
30-Apr-18 FMR 10.60 4,451
30-Apr-18 FMR 10.60 1,594
07-May-18 FMR 10.60 183,670
09-May-18 FMR 10.76 1,205

100080615/3821102.1
3
09-May-18 FMR 10.76 667
09-May-18 FMR 10.76 667
10-May-18 FMR 11.00 616,794
10-May-18 FMR 11.00 411,195
10-May-18 FMR 11.00 176,566
10-May-18 FMR 11.00 117,711
10-May-18 FMR 11.00 9,172
10-May-18 FMR 11.00 6,115
10-May-18 FMR 11.00 70,366
10-May-18 FMR 11.00 46,911
10-May-18 FMR 11.00 9,470
10-May-18 FMR 11.00 6,313
10-May-18 FMR 11.00 17,632
10-May-18 FMR 11.00 11,755

Total Buys 2,059,830

Transition in 49,203

Total 2,109,033


Additional information
Address(es) of substantial product holder(s): Refer to annexure A
Contact details: Ryo Sato, Regulatory Reporting Manager, FIL Asia Holdings Pte Limited,
+852 2629 2657
Name of any other person believed to have given, or believed to be required to give, a
disclosure under the Financial Markets Conduct Act 2013 in relation to the financial
products to which this disclosure relates: N/A
Certification
I, Ryo Sato, certify that, to the best of my knowledge and belief, the information contained
in this disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.


________________________________

Dated: 11 May 2018

Ryo Sato
Regulatory Reporting Manager
Duly authorised under Powers of Attorney by and on behalf of FMR LLC.

100080615/3821102.1
4